Canadian Cancer Society research chairs
11 October 2011
The Canadian Cancer Society New Brunswick, in partnership with the University of New Brunswick, the Université de Moncton and the Atlantic Cancer Research Institute, introduced two new Canadian Cancer Society research chairs today.
“The Canadian Cancer Society has a long history of funding cancer research in Canada and we are very excited by the promise of Dr. Reiman’s and Dr. Turcotte’s contribution in the fight against cancer,” said Anne McTiernan-Gamble, CEO of the Canadian Cancer Society New Brunswick. “Our investment, made possible by donors and volunteers, is a significant part of the momentum advancing cancer research in this province.”
Dr. Anthony Reiman has been named as the Canadian Cancer Society Research Chair at the University of New Brunswick, while Dr. Sandra Turcotte will serve as the Canadian Cancer Society Research Chair at the Université de Moncton. Dr. Turcotte’s research will focus on kidney cancer. “The Canadian Cancer Society research chair is a wonderful opportunity to expand my research and develop more effective therapies for advanced or metastatic renal cell carcinoma,” Dr. Turcotte explained. “It is also an opportunity to work in collaboration with a team of experienced researchers.”
As a practising oncologist and researcher, Dr. Reiman’s focus will be patient-centred. “My research revolves around the people I see every day who have been diagnosed with cancer,” Dr. Reiman said. “My goal is to help researchers, clinicians and cancer survivors across this province come together to be part of the solution to better manage the burden of this disease.”
The establishment of the Canadian Cancer Society research chairs represents a 14-year commitment by the Canadian Cancer Society New Brunswick totaling $3.1 million. This investment will help to leverage additional funds from other institutions, further enhancing the cancer research capacity in New Brunswick.
“The opportunity to work with these research chairs is tremendous and we are very pleased to welcome them both to our team,” said Dr. Rodney Ouellette, President and Scientific Director of the Atlantic Cancer Research Institute. “These types of collaborations are key to enable discoveries that translate into solutions for cancer patients.”
“The establishment of these research chairs represents additional resources in the health field, which is one of our major development priorities,” said Yvon Fontaine, President and Vice-Chancellor of the Université de Moncton.
"We're thrilled to have the opportunity to partner with other institutions across the province to enhance cancer research," said Dr. Eddy Campbell, President and Vice-Chancellor of the University of New Brunswick. "This is extremely important research that will have an impact on our communities here at home and I thank the Canadian Cancer Society for their support and for launching this initiative.”
The Canadian Cancer Society is a national community-based organization of volunteers whose mission is the eradication of cancer and the enhancement of the quality of life of people living with cancer. When you want to know more about cancer, visit our website www.cancer.ca or call our toll-free, bilingual Cancer Information Service at 1 888 939-3333.